Gene · 1263
Papers1,568
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,568
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An updated landscape on nanotechnology-based drug delivery, immunotherapy, vaccinations, imaging, and biomarker detections for cancers: recent trends and future directions with clinical success. | Discov Nano | 2023 | 38112935 | PubTator, text mining | PubMed |
| Adhesion G Protein-Coupled Receptor G2 Promotes Hepatocellular Carcinoma Progression and Serves as a Neutrophil-Related Prognostic Biomarker. | Int J Mol Sci | 2023 | 38069309 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Native Kentucky Bluegrass (Poa pratensis L.) in Response to Osmotic Stress. | Plants (Basel) | 2023 | 38068609 | PubTator, text mining | PubMed |
Rendezvous intervention using combined surgical carotid endarterectomy followed by endovascular thrombectomy in patients with acute tandem occlusions: a proof-of-concept experience at a tertiary care center. | Neurol Res Pract | 2023 | 38057910 | PubTator, text mining | PubMed |
| Integrative analysis of the molecular signature of target genes involved in the antitumor effects of cantharidin on hepatocellular carcinoma. | BMC Cancer | 2023 | 38017425 | PubTator, text mining | PubMed |
| Leveraging the Fragment Molecular Orbital Method to Explore the PLK1 Kinase Binding Site and Polo-Box Domain for Potent Small-Molecule Drug Design. | Int J Mol Sci | 2023 | 37958623 | PubTator, text mining | PubMed |
| Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies. | Cancers (Basel) | 2023 | 37958442 | PubTator, text mining | PubMed |
| Factors affecting quality of life in women with breast cancer: a path analysis. | BMC Womens Health | 2023 | 37940922 | PubTator, text mining | PubMed |
| Diverse roles of biomolecular condensation in eukaryotic translational regulation. | RNA Biol | 2023 | 37906632 | PubTator, text mining | PubMed |
| Chronic HCV infection promotes cytotoxicity in antigen-specific CD8+ T cells regardless of virus specificity. | Front Virol | 2023 | 37886042 | PubTator, text mining | PubMed |
| Evaluation of the efficiency and safety of TransPRK and FS-LASIK refractive procedures on patients with astigmatism and amblyopia. | Rom J Ophthalmol | 2023 | 37876510 | PubTator, text mining | PubMed |
| PLK3 facilitates replication of swine influenza virus by phosphorylating viral NP protein. | Emerg Microbes Infect | 2023 | 37874309 | PubTator, text mining | PubMed |
| Consensus cluster analysis of apoptosis-related genes in patients with osteoarthritis and their correlation with immune cell infiltration. | Front Immunol | 2023 | 37860011 | PubTator, text mining | PubMed |
| High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma. | Cell Rep Med | 2023 | 37858338 | PubTator, text mining | PubMed |
| Chromatin compartmentalization regulates the response to DNA damage. | Nature | 2023 | 37853125 | PubTator, text mining | PubMed |
| PAK1 and Therapy Resistance in Melanoma. | Cells | 2023 | 37830586 | PubTator, text mining | PubMed |
| A nightmare of clopidogrel resistance in a resource-limited setting: case report of subacute stent thrombosis. | Egypt Heart J | 2023 | 37823944 | PubTator, text mining | PubMed |
| Proteomic and Phosphoproteomic Reprogramming in Epithelial Ovarian Cancer Metastasis. | Mol Cell Proteomics | 2023 | 37820923 | PubTator, text mining | PubMed |
| Xuanfei Baidu decoction in the treatment of coronavirus disease 2019 (COVID-19): Efficacy and potential mechanisms. | Heliyon | 2023 | 37809901 | PubTator, text mining | PubMed |
| Human cytomegalovirus UL36 inhibits IRF3-dependent immune signaling to counterbalance its immunoenhancement as apoptotic inhibitor. | Sci Adv | 2023 | 37792941 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1263/papers?page=5